Concepedia

Effect on coronary flow velocity reserve in patients with type 2 diabetes mellitus: Comparison between angiotensin-converting enzyme inhibitor and angiotensin II type 1 receptor antagonist

Takayuki Kawata, Masao Daimon, Rei Hasegawa, Kiyomi Teramoto, Tomohiko Toyoda, Tai Sekine, Kyohei Yamamoto, Daigaku Uchida, Toshiharu Himi, Katsuya Yoshida,

American Heart Journal · 2006 · 38 citations · 28 references

DOI

Concepts

References

28

Effects of an Angiotensin-Converting–Enzyme Inhibitor, Ramipril, on Cardiovascular Events in High-Risk Patients

New England Journal of Medicine · 2000 · 8.7K citations · Full text

, , +16

Effect of Enalapril on Survival in Patients with Reduced Left Ventricular Ejection Fractions and Congestive Heart Failure

New England Journal of Medicine · 1991 · 8.1K citations · Full text

, , +12

Effects of Losartan on Renal and Cardiovascular Outcomes in Patients with Type 2 Diabetes and Nephropathy

Barry M. Brenner, Mark E. Cooper, Dick de Zeeuw et al. · New England Journal of Medicine · 2001 · 7.5K citations · Full text

, , +17

Global Burden of Diabetes, 1995–2025: Prevalence, numerical estimates, and projections

Hilary King, Ronald E. Aubert, William H. Herman · Diabetes Care · 1998 · 6.3K citations

, , +14

Renoprotective Effect of the Angiotensin-Receptor Antagonist Irbesartan in Patients with Nephropathy Due to Type 2 Diabetes

Edmund J. Lewis, Lawrence G. Hunsicker, William R. Clarke et al. · New England Journal of Medicine · 2001 · 6K citations · Full text

, , +16